Sponsors

VIROLOGY ARTICLES

The developing market landscape for HIV rapid diagnostic tests

A recently published report into the HIV rapid diagnostic test market landscape, produced in coordination with the World Health Organization, aims for a healthier, more sustainable market. Here, Pathology in Practice presents a summary of the report, including the current state of HIV testing and aims for the near future.

The new normal – adapting to the new era of winter respiratory diseases

Over the last few years, we’ve all witnessed the toll that overwhelming caseloads of COVID-19, influenza A/B and RSV testing can have on healthcare settings. The resulting push for more accurate and discriminatory methods to aid the management of patients presenting with respiratory and/or flu-like symptoms has highlighted the importance of developing a test panel that is both efficient and clinically relevant, says Dr Andrew Birnie.

Rapid point-of-care testing: an important tool in virus management

Royal Derby Hospital operates robust point-of-care testing as part of its virus management programme, and implementation of year-round respiratory syncytial virus testing last year resulted in the discovery of an unexpected summer surge in cases, as Yusuf Gray explains.

Innovation Lab supports Newcastle University study into new COVID-19 test

The North East Innovation Lab works to assess and accelerate the development of new diagnostic tests. Pathology in Practice looks at the support it provided to a study assessing the use of synthetic polymer antibodies in a new test for SARS-CoV-2.

Future-proofing diagnostic testing: examples of innovation

A specialist NHS laboratory, hosted by Newcastle Hospitals, is helping to accelerate the development of new, cutting-edge COVID-19 tests, as well as technologies that could give an early warning of virus threats.

SARS-CoV-2 coronavirus and COVID-19 disease: a pandemic story update

Pathology services continue to face challenges to detect the SARS-CoV-2 coronavirus. Here, Sarah Pitt provides a further update on the virology, epidemiology, testing and treatment of this mutating agent of pandemic disease.

HPV: a virus in decline thanks to screening and vaccination

As a result of continued research and development, the incidence of death from cancers caused by human papillomavirus infection is falling. Here, Neil Bentley provides an overview and looks at the impact of screening and diagnostic testing.

Latest Issues